Henan Purui Pharmaceutical Co., Ltd. was established in 2004. The company is a pharmaceutical group integrating of scientific research, production and trade. It is located in Zhoukou City, Henan Province, a national historical and cultural city. There are over 400 employees. The company's main business includes the production and sales of APIs, pharmaceutical intermediates, tablets, capsules and injections, of which anticholinergic APIs and preparations account for about 60% of the national market share.
Henan Purui Pharmaceutical Co., Ltd. is located in Xihua County Industrial Agglomeration area, Henan Province, covers an area of more than 120,000 square meters. The company strictly implements the national "Drug Production Management Standards". The company is a professional manufacturer of cardiovascular and cerebrovascular, anti-tumor, new antibiotics, anti-cholinergic and other apis and national emergency medicine raw materials and intermediates, and a national GMP certified enterprise. At the same time, the company has applied for US DMF documents on atropine sulfate, pentoxyverine citrate, betahistine, fluconazole, magnesium sulfate, potassium chloride and other API products.
Henan Purui Pharmaceutical Co., Ltd. has strong research and development force. The company has a drug innovation research and development center in Zhengzhou High-tech Industrial Development Zone, specializing in drug research and development, application, technology transfer. The R&D center has more than 30 experienced professional and technical personnel, including 2 doctoral degrees and 10 postgraduate degrees. The company has imported 20 sets of liquid phase, imported high performance liquid phase chromatograph, gas chromatograph, ultraviolet spectrophotometer, infrared spectrophotometer, polarimeter, analysis balance, intelligent dissolution instrument and a large number of perfect and advanced precision instruments and equipment. Based on the market demand for scientific and technological innovation, the company has established long-term and extensive strategic cooperative relations with scientific research institutions such as Peking University, Institute of Materia Medica of Shanghai Fudan University, Shanghai Medical Engineering Institute, and School of Pharmacy of Zhengzhou University.
At present, the company is completing the construction of the second production base in Zhengzhou National high-tech biomedical Base. The production base covers an area of 70,000 square meters, with a total investment of more than 300 million yuan, and will be built strictly in accordance with the US CGMP standards. After the actual production, it will pass the relevant certifications such as domestic GMP, US CGMP and EU CEP.
The company adheres to the management principle of "quality first, people-oriented" and the spirit of enterprise of "advancing with The Times, pioneering and forging ahead", and constantly pioneering and forging ahead in the field of medicine. Relying on efficient management team, professional R & D personnel and dedicated marketing team, Purui people are working hard for the healthy life of human beings.